Posted by Michael Wonder on 09 Oct 2018
Outdated public funding model failing New Zealand patients
9 October 2018 - Publicly funded modern medicines are out of reach for many patients in New Zealand according to a new report.
The COMPARE 4 report shows New Zealand ranking the lowest out of 20 OECD countries for its market access to modern medicines.
New Zealand’s market access score of 12% is a long way from 19th placed Portugal.
